{"id":"https://openalex.org/W2114880160","doi":"https://doi.org/10.1038/sj.clpt.6100160","title":"Developing Strategies to Link Basic Cardiovascular Sciences with Clinical Drug Development: Another Opportunity for Translational Sciences","display_name":"Developing Strategies to Link Basic Cardiovascular Sciences with Clinical Drug Development: Another Opportunity for Translational Sciences","publication_year":2007,"publication_date":"2007-03-28","ids":{"openalex":"https://openalex.org/W2114880160","doi":"https://doi.org/10.1038/sj.clpt.6100160","mag":"2114880160","pmid":"https://pubmed.ncbi.nlm.nih.gov/17392727"},"language":"en","primary_location":{"id":"doi:10.1038/sj.clpt.6100160","doi":"https://doi.org/10.1038/sj.clpt.6100160","is_oa":false,"landing_page_url":"https://doi.org/10.1038/sj.clpt.6100160","pdf_url":null,"source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology & Therapeutics","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5000060972","display_name":"Arthur Michael Feldman","orcid":"https://orcid.org/0000-0001-8351-9569","observed_orcids":["https://orcid.org/0000-0001-8351-9569"]},"institutions":[{"id":"https://openalex.org/I149251103","display_name":"Thomas Jefferson University","ror":"https://ror.org/00ysqcn41","country_code":"US","type":"education","lineage":["https://openalex.org/I149251103"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"A M Feldman","raw_affiliation_strings":["Department of Medicine, Jefferson Medical College, Philadelphia, Pennsylvania, USA. arthur.feldman@jefferson.edu","Department of Medicine, Jefferson Medical College Philadelphia Pennsylvania USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Jefferson Medical College, Philadelphia, Pennsylvania, USA. arthur.feldman@jefferson.edu","institution_ids":["https://openalex.org/I149251103"]},{"raw_affiliation_string":"Department of Medicine, Jefferson Medical College Philadelphia Pennsylvania USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075648082","display_name":"Walter J. Koch","orcid":"https://orcid.org/0000-0002-8522-530X","observed_orcids":["https://orcid.org/0000-0002-8522-530X","https://orcid.org/0000-0002-0609-8649"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"W J Koch","raw_affiliation_strings":["Department of Medicine, Jefferson Medical College, Philadelphia, Pennsylvania, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Jefferson Medical College, Philadelphia, Pennsylvania, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5017332459","display_name":"Thomas L. Force","orcid":"https://orcid.org/0000-0002-0450-8659","observed_orcids":["https://orcid.org/0000-0002-0450-8659"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T L Force","raw_affiliation_strings":["Department of Medicine, Jefferson Medical College, Philadelphia, Pennsylvania, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Jefferson Medical College, Philadelphia, Pennsylvania, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5000060972"],"corresponding_institution_ids":["https://openalex.org/I149251103"],"apc_list":{"value":4410,"currency":"USD","value_usd":4410},"apc_paid":null,"fwci":0.5476,"has_fulltext":false,"cited_by_count":19,"citation_normalized_percentile":{"value":0.46478873,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"81","issue":"6","first_page":"887","last_page":"892"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12281","display_name":"Animal testing and alternatives","score":0.9398999810218811,"subfield":{"id":"https://openalex.org/subfields/3404","display_name":"Small Animals"},"field":{"id":"https://openalex.org/fields/34","display_name":"Veterinary"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12281","display_name":"Animal testing and alternatives","score":0.9398999810218811,"subfield":{"id":"https://openalex.org/subfields/3404","display_name":"Small Animals"},"field":{"id":"https://openalex.org/fields/34","display_name":"Veterinary"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10217","display_name":"Cardiac electrophysiology and arrhythmias","score":0.015599999576807022,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12168","display_name":"Health and Medical Research Impacts","score":0.008999999612569809,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/translational-medicine","display_name":"translational medicine","score":0.8009999990463257},{"id":"https://openalex.org/keywords/cardiovascular-drug-development","display_name":"cardiovascular drug development","score":0.9769999980926514},{"id":"https://openalex.org/keywords/cardiotoxicity","display_name":"cardiotoxicity","score":0.7799999713897705},{"id":"https://openalex.org/keywords/animal-models","display_name":"animal models","score":0.8489999771118164},{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":0.7919999957084656},{"id":"https://openalex.org/keywords/cyclooxygenase-inhibitors","display_name":"cyclooxygenase inhibitors","score":0.996999979019165},{"id":"https://openalex.org/keywords/adenosine-receptor-agonists","display_name":"adenosine receptor agonists","score":0.9350000023841858},{"id":"https://openalex.org/keywords/adenosine-receptor-antagonists","display_name":"adenosine receptor antagonists","score":0.9660000205039978},{"id":"https://openalex.org/keywords/clinical-trial-design","display_name":"clinical trial design","score":0.8339999914169312},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.5619999766349792}],"concepts":[{"id":"https://openalex.org/C162264550","wikidata":"https://www.wikidata.org/wiki/Q17112037","display_name":"Translational medicine","level":2,"score":0.6844671368598938},{"id":"https://openalex.org/C2778233292","wikidata":"https://www.wikidata.org/wiki/Q2118956","display_name":"Cardiotoxicity","level":3,"score":0.6171021461486816},{"id":"https://openalex.org/C128544194","wikidata":"https://www.wikidata.org/wiki/Q474859","display_name":"Translational research","level":2,"score":0.6033214330673218},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5976940989494324},{"id":"https://openalex.org/C57634137","wikidata":"https://www.wikidata.org/wiki/Q474859","display_name":"Translational science","level":2,"score":0.5702420473098755},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5686546564102173},{"id":"https://openalex.org/C63433958","wikidata":"https://www.wikidata.org/wiki/Q1774688","display_name":"Clinical pharmacology","level":2,"score":0.5629917979240417},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.5341001749038696},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4814566969871521},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.40987828373908997},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.32726192474365234},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.14231649041175842},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.12483265995979309},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.08425760269165039}],"mesh":[{"descriptor_ui":"D000068878","descriptor_name":"Trastuzumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004059","descriptor_name":"Diffusion of Innovation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D035843","descriptor_name":"Biomedical Research","qualifier_ui":"Q000458","qualifier_name":"organization & administration","is_major_topic":true},{"descriptor_ui":"D052246","descriptor_name":"Cyclooxygenase 2 Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D052246","descriptor_name":"Cyclooxygenase 2 Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D058915","descriptor_name":"Purinergic P1 Receptor Antagonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D064420","descriptor_name":"Drug-Related Side Effects and Adverse Reactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1038/sj.clpt.6100160","doi":"https://doi.org/10.1038/sj.clpt.6100160","is_oa":false,"landing_page_url":"https://doi.org/10.1038/sj.clpt.6100160","pdf_url":null,"source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology & Therapeutics","raw_type":"journal-article"},{"id":"pmid:17392727","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17392727","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical pharmacology and therapeutics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.41999998688697815}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":60,"referenced_works":["https://openalex.org/W275107321","https://openalex.org/W1520023565","https://openalex.org/W1559873189","https://openalex.org/W1603672218","https://openalex.org/W1965992514","https://openalex.org/W1970592808","https://openalex.org/W1978998797","https://openalex.org/W1981876883","https://openalex.org/W1985844039","https://openalex.org/W1993174153","https://openalex.org/W1998990808","https://openalex.org/W2003016773","https://openalex.org/W2010224507","https://openalex.org/W2012801178","https://openalex.org/W2016071225","https://openalex.org/W2017877447","https://openalex.org/W2018716226","https://openalex.org/W2025653938","https://openalex.org/W2040794497","https://openalex.org/W2044750065","https://openalex.org/W2047808472","https://openalex.org/W2050674912","https://openalex.org/W2052396447","https://openalex.org/W2052512448","https://openalex.org/W2055691692","https://openalex.org/W2061857216","https://openalex.org/W2071316578","https://openalex.org/W2080477342","https://openalex.org/W2080605484","https://openalex.org/W2082802659","https://openalex.org/W2085270986","https://openalex.org/W2085698001","https://openalex.org/W2089107052","https://openalex.org/W2091276489","https://openalex.org/W2091998576","https://openalex.org/W2092429540","https://openalex.org/W2097767970","https://openalex.org/W2112636933","https://openalex.org/W2115475125","https://openalex.org/W2124336386","https://openalex.org/W2127154601","https://openalex.org/W2127181560","https://openalex.org/W2127874769","https://openalex.org/W2130271956","https://openalex.org/W2138298403","https://openalex.org/W2139631630","https://openalex.org/W2140074016","https://openalex.org/W2140292987","https://openalex.org/W2146384083","https://openalex.org/W2152021373","https://openalex.org/W2154656177","https://openalex.org/W2157606815","https://openalex.org/W2160540392","https://openalex.org/W2163149796","https://openalex.org/W2164290354","https://openalex.org/W2164323243","https://openalex.org/W2318605753","https://openalex.org/W2330496155","https://openalex.org/W2409624051","https://openalex.org/W2418327139"],"related_works":["https://openalex.org/W2560499280","https://openalex.org/W2049236096","https://openalex.org/W2029053821","https://openalex.org/W2017167105","https://openalex.org/W4206215027","https://openalex.org/W1985883897","https://openalex.org/W2979409238","https://openalex.org/W2045017687","https://openalex.org/W4407027400","https://openalex.org/W2511950217"],"abstract_inverted_index":{"Driven,":[0],"at":[1],"least":[2],"in":[3,23,39,54,61,71,155],"part,":[4],"by":[5,111],"the":[6,19,24,29,55,63,80,94,118,122,126,130,142,160],"National":[7],"Institutes":[8],"of":[9,15,57,67,83,97,102,144,162],"Health":[10],"roadmap,":[11],"an":[12,36],"increasing":[13],"number":[14],"studies":[16,33,116],"has":[17,49],"bridged":[18],"chasm":[20],"between":[21],"observations":[22],"basic":[25],"research":[26],"laboratory":[27,115],"and":[28,129,133],"clinical":[30,98,151],"bedside.":[31],"These":[32],"have":[34,108],"been":[35,50,109],"integral":[37],"part":[38],"\"translating\"":[40],"new":[41,84,163],"discoveries":[42],"into":[43],"therapeutic":[44,85],"initiatives.":[45],"However,":[46],"\"translational":[47],"medicine\"":[48],"used":[51],"less":[52],"frequently":[53],"development":[56,104,119],"cardiovascular":[58,65],"drugs":[59],"or":[60],"predicting":[62],"potential":[64,81],"toxicity":[66],"non-cardiac":[68],"agents.":[69,165],"Studies":[70],"animal":[72],"models":[73,137],"can":[74,153],"provide":[75,147],"important":[76,148],"clues":[77,112],"as":[78,87,89],"to":[79],"cardiotoxicity":[82],"agents,":[86],"well":[88],"providing":[90],"a":[91],"template":[92],"for":[93,121,159],"rational":[95],"design":[96],"trials.":[99],"Three":[100],"examples":[101],"drug":[103,124],"programs":[105,120,158],"that":[106,150],"might":[107],"altered":[110],"available":[113],"from":[114],"include":[117],"anti-cancer":[123],"trastuzumab,":[125],"cyclooxygenase":[127],"inhibitors,":[128],"adenosine-receptor":[131],"agonists":[132],"antagonists.":[134],"Although":[135],"mouse":[136],"may":[138],"not":[139],"always":[140],"represent":[141],"physiology":[143],"humans,":[145],"they":[146],"information":[149],"scientists":[152],"utilize":[154],"designing":[156],"safe":[157],"evaluation":[161],"pharmacologic":[164]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}